Insider · CIK 0002031342
Rebecca Luse
Files at LBRX (LB PHARMACEUTICALS INC). First filing -, latest -.
In brief
Rebecca Luse files SEC Form 4 as director at LBRX (LB PHARMACEUTICALS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rebecca Luse has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | LBRX LB PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Jun 5, 2026 |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +22,449 | $0.00 | $0 | 22,449 | Sep 12, 2025 |
Questions about Rebecca Luse
Answered from the filings on this page, as of the latest one.
Is Rebecca Luse buying or selling?
Rebecca Luse has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rebecca Luse's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rebecca Luse has 0.
Where does Rebecca Luse file Form 4?
Rebecca Luse has filed Form 4 at LBRX (LB PHARMACEUTICALS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.